XCAFX: Morgan Stanley China A Share Fund - MutualFunds.com
Continue to site >
Trending ETFs

Welcome to MutualFunds.com

Please help us personalize your experience and select the one that best describes you.

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission

We hope you enjoy your experience

MS China A Share

XCAFX - Snapshot

Vitals

  • YTD Return 2.7%
  • 3 Yr Annualized Return 2.7%
  • 5 Yr Annualized Return 10.9%
  • Net Assets $580 M
  • Holdings in Top 10 47.9%

52 WEEK LOW AND HIGH

$26.10
$22.83
$28.14

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.75%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 112.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

  • Standard (Taxable) N/A
  • IRA N/A

Fund Classification


Compare XCAFX to Popular China Region Equity Funds and ETFs

Overview

Income Profile

Income Risk

Returns Profile

Allocations

Expenses

About

$81.76

+0.49%

$7.19 B

1.03%

$0.84

0.63%

0.59%

$63.49

+1.23%

$7.04 B

1.55%

$0.97

19.67%

0.59%

$46.18

+0.22%

$4.70 B

2.21%

$1.02

-0.78%

0.74%

-

-

$4.33 B

-

$0.22

-10.08%

0.73%

$41.49

+0.95%

$2.72 B

0.79%

$0.32

1.97%

0.65%

XCAFX - Profile

Distributions

  • YTD Total Return 2.7%
  • 3 Yr Annualized Total Return 2.7%
  • 5 Yr Annualized Total Return 10.9%
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio 0.60%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    Morgan Stanley China A Share Fund
  • Fund Family Name
    Morgan Stanley
  • Inception Date
    Sep 28, 2006
  • Shares Outstanding
    21881465
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Gary Cheung

Fund Description

N/A


XCAFX - Performance

Return Ranking - Trailing

Period XCAFX Return Category Return Low Category Return High Rank in Category (%)
YTD 2.7% -39.3% 41.6% 57.48%
1 Yr 30.3% 10.9% 131.6% 87.60%
3 Yr 2.7%* -5.4% 23.8% 93.55%
5 Yr 10.9%* 3.1% 27.5% 86.21%
10 Yr 9.2%* -2.7% 14.1% 33.33%

* Annualized

Return Ranking - Calendar

Period XCAFX Return Category Return Low Category Return High Rank in Category (%)
2020 2.0% -21.7% 138.4% 94.55%
2019 15.0% -1.9% 46.9% 77.67%
2018 -24.0% -52.1% -5.1% 48.28%
2017 35.4% 7.9% 78.5% 56.96%
2016 -11.5% -54.3% 130.0% 84.62%

Total Return Ranking - Trailing

Period XCAFX Return Category Return Low Category Return High Rank in Category (%)
YTD 2.7% -39.3% 42.0% 59.06%
1 Yr 30.3% 10.9% 131.6% 87.60%
3 Yr 2.7%* -5.4% 23.8% 93.55%
5 Yr 10.9%* 3.1% 27.5% 86.21%
10 Yr 9.2%* -2.7% 14.1% 31.94%

* Annualized

Total Return Ranking - Calendar

Period XCAFX Return Category Return Low Category Return High Rank in Category (%)
2020 2.0% -21.7% 138.4% 94.55%
2019 15.0% -1.9% 46.9% 77.67%
2018 -24.0% -52.1% -5.0% 60.92%
2017 35.4% 7.9% 78.5% 63.29%
2016 -11.5% -30.2% 18.0% 88.46%

NAV & Total Return History


XCAFX - Holdings

Concentration Analysis

XCAFX Category Low Category High XCAFX % Rank
Net Assets 580 M 1.71 M 7.19 B 17.56%
Number of Holdings 45 23 908 76.74%
Net Assets in Top 10 267 M 918 K 3.09 B 16.28%
Weighting of Top 10 47.93% 8.3% 73.0% 52.71%

Top 10 Holdings

  1. China Resources Sanjiu Medical & Pharmaceutical Co Ltd 9.51%
  2. China Resources Sanjiu Medical & Pharmaceutical Co Ltd 9.51%
  3. China Resources Sanjiu Medical & Pharmaceutical Co Ltd 9.51%
  4. China Resources Sanjiu Medical & Pharmaceutical Co Ltd 9.51%
  5. China Resources Sanjiu Medical & Pharmaceutical Co Ltd 9.51%
  6. China Resources Sanjiu Medical & Pharmaceutical Co Ltd 9.51%
  7. China Resources Sanjiu Medical & Pharmaceutical Co Ltd 9.51%
  8. China Resources Sanjiu Medical & Pharmaceutical Co Ltd 9.51%
  9. China Resources Sanjiu Medical & Pharmaceutical Co Ltd 9.51%
  10. China Resources Sanjiu Medical & Pharmaceutical Co Ltd 9.51%

Asset Allocation

Weighting Return Low Return High XCAFX % Rank
Stocks
98.31% 62.11% 103.01% 44.19%
Cash
1.40% -1.43% 9.52% 58.91%
Bonds
0.29% 0.00% 2.03% 1.55%
Preferred Stocks
0.00% 0.00% 0.00% 6.20%
Other
0.00% -6.51% 36.92% 17.83%
Convertible Bonds
0.00% 0.00% 0.00% 6.20%

Bond Sector Breakdown

Weighting Return Low Return High XCAFX % Rank
Cash & Equivalents
100.00% 0.00% 100.00% 5.47%
Derivative
0.00% 0.00% 100.00% 17.97%
Securitized
0.00% 0.00% 0.00% 6.25%
Corporate
0.00% 0.00% 87.91% 7.03%
Municipal
0.00% 0.00% 0.00% 6.25%
Government
0.00% 0.00% 0.00% 6.25%

Bond Geographic Breakdown

Weighting Return Low Return High XCAFX % Rank
US
0.29% 0.00% 0.29% 0.78%
Non US
0.00% 0.00% 2.03% 6.98%

XCAFX - Expenses

Operational Fees

XCAFX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.75% 0.09% 21.25% 36.07%
Management Fee 1.50% 0.09% 1.50% 100.00%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee 0.08% 0.03% 0.26% 21.88%

Sales Fees

XCAFX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.50% 5.75% N/A
Deferred Load N/A 1.00% 1.00% N/A

Trading Fees

XCAFX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 2.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

XCAFX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 112.00% 7.00% 243.00% 86.55%

XCAFX - Distributions

Dividend Yield Analysis

XCAFX Category Low Category High XCAFX % Rank
Dividend Yield 0.00% 0.00% 3.07% 26.52%

Dividend Distribution Analysis

XCAFX Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Semi-Annually Annually

Net Income Ratio Analysis

XCAFX Category Low Category High XCAFX % Rank
Net Income Ratio 0.60% -1.66% 5.16% 35.25%

Capital Gain Distribution Analysis

XCAFX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually

Dividend Payout History

View More +

XCAFX - Fund Manager Analysis

Managers

Gary Cheung


Start Date

Tenure

Tenure Rank

Jan 30, 2017

4.33

4.3%

Gary focuses on China & China A shares for our Asian Equity strategies. He joined Morgan Stanley in 2008 and has 14 years of investment experience. Prior to joining the firm, Gary was a macro equity analyst at Tudor Investment. Previously, Gary was an investment banking analyst at Credit Suisse focusing on corporate financial strategies. Gary received a B.S. summa cum laude in industrial and management engineering from Rensselaer Polytechnic Institute, and an M.S. in financial engineering from Columbia University. He holds the Chartered Financial Analyst designation.

May Yu


Start Date

Tenure

Tenure Rank

Jan 30, 2017

4.33

4.3%

May is a portfolio manager for the Asian Equity strategy, focusing on China and Hong Kong. She re-joined Morgan Stanley in 2012 and has 18 years of investment experience. May was previously with the Asian Equity team from 2006 to early 2011, dedicated to China investing. Prior to re-joining Morgan Stanley, she was lead portfolio manager at China International Capital Corporation (CICC) for long-only China/Hong Kong equity. Earlier in her career, May was an assistant director in China research at BNP Paribas Peregrine from a base in Beijing. She also worked as a manager for China Cinda Asset Management and China Construction Bank. May has received a Bachelor?s in Engineering and Industrial Management from Dalian University of Technology, a Master of Economics in Finance from the Graduate School of the People?s Bank of China and an M.B.A. from NYU?s Stern School of Business.

Leon Sun


Start Date

Tenure

Tenure Rank

Mar 31, 2021

0.17

0.2%

Leon is an investor on the Global Emerging Markets team, and the lead portfolio manager for the China strategies. Leon is also a co-portfolio manager for the Asia regional strategies. He joined Morgan Stanley in 2021 and has 23 years of investment experience. Prior to joining the firm, he worked as a senior portfolio manager and head of investment for China and Hong Kong at Nomura Asset Management. He was also an investment analyst at Martin Currie and a credit officer at Bank of China. Leon received a B.A. in English from Shanghai International Studies University and a Msc. in finance and investment from The University of Edinburgh. He holds the Chartered Financial Analyst designation.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.03 27.32 3.31 0.41